Artificial Pancreas Device System Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What External and Internal Drivers Are Contributing to the Growth of theArtificial Pancreas Device System Market?
The artificial pancreas device system market is anticipated to expand due to the rising occurrences of pancreatic cancer. This cancer, a malignant tumor originating in the pancreas – a gland situated behind the stomach, is influenced by various factors including lifestyle, genetic makeup, health conditions, and environment. Genetic mutations leading to hereditary pancreatitis, which can cause prolonged inflammation of the pancreas, are also contributory factors. An artificial pancreas device system (APDS) is principally created to aid those suffering from diabetes in monitoring their glucose levels and administering suitable insulin doses. In support of this, data from Cancer Australia – a government agency, showed that as of March 2024, the cases of pancreatic cancer diagnosed in 2023 had increased to 4,506 from 3,751 in the last five years. Hence, the rising cases of pancreatic cancer are promoting the growth of the artificial pancreas device system market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp
#How Will the CAGR of the Artificial Pancreas Device System Market Influence Its Overall Growth by 2034?
The market for artificial pancreas device systems has experienced significant expansion in the past few years. The market is projected to increase from $1.81 billion in 2024 to $2.07 billion in 2025, with a compound annual growth rate (CAGR) of 14.1%. Factors contributing to this growth during the historic period include an surge in investment, enhanced government participation in clinical research, a rising demand for automated glycemic control systems, sustained research and development activities from industry stakeholders, and a growing elderly population.
Expectations are high for the artificial pancreas device system market to experience quick expansion in the coming years. By 2029, projections indicate a growth to a hefty $3.48 billion, following a compound annual growth rate (CAGR) of 13.9%. This predicted growth within the forecast period can be accredited to the escalating prevalence of conditions such as diabetes and pancreatic cancer, as well as an increase in instances of diabetes and obesity. Other factors contributing to this growth include the rising demand for minimally invasive drug delivery systems and innovation in diabetes management technology. Furthermore, significant trends expected to be seen during the forecast period encompass technological advances, boosted research and development endeavours, a rise in product approvals, an acceleration of collaborations and partnerships, and an upsurge in teleconsultation activity for patient follow-ups.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18229
Which Upcoming Market Trends and Innovations Are Set to Influence theArtificial Pancreas Device System Market’s Path Forward?
Top firms involved in the artificial pancreas device system market are working towards creating automated insulin delivery systems. These systems are designed to improve diabetes management by autonomously tracking blood sugar levels and administering the required dose of insulin, replicating the role of a healthy pancreas. They aim to alleviate the inconvenience of regularly monitoring blood sugar levels and dispensing insulin manually for diabetics. For example, in May 2023, Beta Bionics, a medical equipment producer based in the US, gained FDA 510(k) approval for their iLet Insulin-Only Bionic Pancreas System. This automated insulin delivery device is an artificial pancreas system that self-regulates and delivers insulin doses to maintain regular blood glucose levels. Acting as a closed-loop system, it adjusts insulin delivery depending on the user’s glucose levels, as tracked by an attached continuous glucose monitor (CGM). The system only needs the user’s body weight and an estimated meal size to adapt the insulin delivery automatically.
Who Are the Dominant Market Players Pushing the Boundaries of theArtificial Pancreas Device System Market?
Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd
Order Your Report Now For A Swift Delivery:
What Are the Core Segments of the Artificial Pancreas Device System Market, and How Do They Contribute to Growth?
The artificial pancreas device system market covered in this report is segmented –
1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid
3) By End-User: Hospitals, Medical Centers, Other End-Users
Subsegments:
1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems
2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems
3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=18229&type=smp
What Regions Are Dominating the Artificial Pancreas Device System Market Growth?
North America was the largest region in the artificial pancreas device system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Artificial Pancreas Device System Market 2025, By The Business Research Company:
Automotive Artificial Intelligence Global Market Report 2024
Artificial Intelligence in Military Global Market Report 2024
Artificial Intelligence in Healthcare Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
